Mahsa Asadi Anar
Overview
Explore the profile of Mahsa Asadi Anar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moannaei M, Jadidian F, Doustmohammadi T, Kiapasha A, Bayani R, Rahmani M, et al.
Biomed Eng Online
. 2025 Mar;
24(1):34.
PMID: 40087776
Background: In recent years, artificial intelligence and machine learning algorithms have been used more extensively to diagnose diabetic retinopathy and other diseases. Still, the effectiveness of these methods has not...
2.
Zangi M, Asadi Anar M, Amirdosara M, Mokhtari M, Goharani R, Sanei Moghaddam S, et al.
Anesth Pain Med
. 2025 Mar;
14(5):e146811.
PMID: 40078655
Context: The enhanced recovery after surgery (ERAS) protocol is a multidisciplinary approach aimed at improving surgical outcomes, reducing complications, minimizing hospital stays, and lowering healthcare costs. Objectives: This study assesses...
3.
Sajjadi S, Mohebbi A, Ehsani A, Marashi A, Azhdarimoghaddam A, Karami S, et al.
Abdom Radiol (NY)
. 2025 Jan;
PMID: 39883167
Background And Aim: Prior investigations of the natural history of abdominal aortic aneurysms (AAAs) have been constrained by small sample sizes or uneven assessments of aggregated data. Natural language processing...
4.
Meybodi S, Karimi M, Mousazadeh K, Khorsand K, Masoumi S, Pakmehr S, et al.
Am J Cardiovasc Dis
. 2025 Jan;
14(6):295-305.
PMID: 39839562
Background And Aim: Sodium-glucose cotransporter two inhibitors can reduce cardiovascular events by modulating lipid profiles in patients with heart failure, irrespective of diabetes status. In this study, we aimed to...
5.
Yousefi M, Akhbari M, Mohamadi Z, Karami S, Dasoomi H, Atabi A, et al.
Front Neurol
. 2024 Dec;
15:1413071.
PMID: 39717687
Background And Aim: Neurodegenerative disorders (e.g., Alzheimer's, Parkinson's) lead to neuronal loss; neurocognitive disorders (e.g., delirium, dementia) show cognitive decline. Early detection is crucial for effective management. Machine learning aids...
6.
Fathi M, Taher H, Al-Rubiae S, Yaghoobpoor S, Bahrami A, Eshraghi R, et al.
World J Methodol
. 2024 Dec;
14(4):93461.
PMID: 39712556
One of the leading causes of cancer-related death is gastrointestinal cancer, which has a significant morbidity and mortality rate. Although preoperative risk assessment is essential for directing patient care, its...
7.
Asadi Anar M, Hassanpour Adeh A, Peiravi S, Imani Porshokouh A, Shojaee S, Najafi F, et al.
Front Neurosci
. 2024 Dec;
18:1426218.
PMID: 39687489
Background And Aim: The neurological processes responsible for irritable bowel syndrome (IBS) pathophysiology and its clinical potentials are not fully understood. The current study aimed to examine white matter microstructural...
8.
Sharifi G, Hajibeygi R, Zamani S, Easa A, Bahrami A, Eshraghi R, et al.
Emerg Radiol
. 2024 Dec;
32(1):97-111.
PMID: 39680295
Background And Aim: The potential intricacy of skull fractures as well as the complexity of underlying anatomy poses diagnostic hurdles for radiologists evaluating computed tomography (CT) scans. The necessity for...
9.
Karimi M, Faal Hamedanchi N, Ansari K, Nahavandi R, Mazdak M, Javaherchian F, et al.
Front Med (Lausanne)
. 2024 Dec;
11:1460676.
PMID: 39635585
Rhabdomyolysis (RML), characterized by the breakdown of skeletal muscle fibers and the release of muscle contents into the bloodstream, has emerged as a notable complication associated with Coronavirus disease 2019...
10.
Ghanikolahloo M, Taher H, Abdullah A, Asadi Anar M, Tayebi A, Rahimi R, et al.
Radiat Oncol
. 2024 Nov;
19(1):164.
PMID: 39563327
Background And Aim: The present study aimed to evaluate the use of F-2-[F]-fluoro-2-deoxy-d-glucose (FDG) PET/MRI (Positron emission tomography-computed tomography) in predicting the pathological response to neoadjuvant chemotherapy (NAC) in patients...